Search
Abcellera Biologics Inc
ABCLAdd to Watchlist
12.310USD
-0.340-2.69%
Close 09-23 16:00（ET）
3.76BMarket Cap
LossP/E TTM
After-hours 17:00 (ET)12.340USD+0.025+0.20%
After-hours 17:00 (ET)Abcellera Biologics Inc (ABCL) Revenue Performance
Updated: Dec 31, 2025By Business
Revenue
Proportion
Annual
Annual
Quarterly
Licensing revenue
Research fees
Milestone payments
FY2025
Licensing revenue
46.92M(62.45%)
Research fees
27.21M(36.22%)
Milestone payments
1.00M(1.33%)